Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 93630
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.93630
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.93630
Figure 1 Expression of DNA methyl transferase 3A/3B and fibrosis-related molecules.
A: Quantitative reverse transcription PCR to detect the expression of miR-29a-3p; B: Western blotting to detect the expression of DNA methyl transferase 3A/3B (DNMT3A/3B), and the right picture shows the statistical analysis map; C: Western blotting; D: Immunofluorescence (× 400) to detect alpha smooth muscle actin (α-SMA), collagen I, and fibronectin expression, and the right picture shows the statistical analysis chart (n = 3). CON: Control group; HG: High glucose group.
- Citation: Yang Y, Chen Y, Tang JY, Chen J, Li GQ, Feng B, Mu J. MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice via downregulation of DNA methyl transferase 3A and 3B. World J Diabetes 2025; 16(4): 93630
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/93630.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.93630